Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial - Takeaways - MDSpire

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

  • By

  • Joris Vangeneugden

  • Saar Vermijs

  • Peter De Kuyper

  • Camille Berquin

  • Nicolaas Lumen

  • Victor Declerck

  • Frederic Baekelandt

  • Christophe Ghysel

  • Yannic Raskin

  • Bernard Bynens

  • Kenzo Mestdagh

  • Pieter De Backer

  • Pieter De Visschere

  • Charlotte Debbaut

  • Charles Van Praet

  • Karel Decaestecker

  • July 17, 2026

Share

  • 1

    The correction addresses the arterial clamping strategy in robot-assisted partial nephrectomy.

  • 2

    The study compares transperitoneal and retroperitoneal approaches in a multicenter randomized controlled trial.

  • 3

    The conflict of interest statement was updated to reflect author PDB's involvement with MEDANNOT s.r.o.

  • 4

    The remaining authors declared no commercial or financial relationships that could be seen as conflicts of interest.

  • 5

    The original article has been updated to include these corrections.

Original Source(s)

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

  • by Joris Vangeneugden, Saar Vermijs, Peter De Kuyper, Camille Berquin, Nicolaas Lumen, Victor Declerck, Frederic Baekelandt, Christophe Ghysel, Yannic Raskin, Bernard Bynens, Kenzo Mestdagh, Pieter De Backer, Pieter De Visschere, Charlotte Debbaut, Charles Van Praet, Karel Decaestecker

  • July 17, 2026

Related Content

Deep learning-based super-resolution dynamic contrast-enhanced radiomics model for predicting NSMP endometrial cancer

Research progress of small molecule targeted drugs for non-small cell lung cancer

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis